Estratégias para aumentar a adesão ao tratamento de Hipertensão Arterial e Diabetes Mellitus na Unidade Básica de Saúde Industrial Americano, em Santa Luzia, Minas Gerais

Abstract

Introduction: Non-communicable chronic diseases (NCDs) represent a significant challenge to public health in Brazil. Among these diseases, hypertension (HTN) and diabetes mellitus (DM) stand out, generating a high demand for consultations in primary care. Justification: The indicators of the Previne Brasil Program include the proportion of hypertensive patients with blood pressure measured during consultations, the proportion of diabetic patients with requested glycated hemoglobin tests, as well as follow-up and adherence to treatment for these patients. The demand for care from the population with DM and HTN is frequent at the Industrial Americano Basic Health Unit (UBS); however, most patients only want to renew their medication prescriptions, which contributes to the low coverage of indicators 6 and 7. which in the first four months of 2024 was 34%. This points to low adherence to treatment and inadequate control of comorbidities and their risk factors. Objective: To develop interventions that promote adherence to treatment and improve the quality of life of this population. Methodology: Includes a literature review on the relationship between DM and HA, emphasizing risk factors and interventions. The healthcare team will conduct a situational diagnosis to identify problems in the follow-up of these patients. Continuing education for the team will be promoted through free courses from the Ministry of Health, supplemented by monthly summaries. Educational activities in the waiting room will involve all team members, and an operational group for hypertensive and diabetic patients will be developed. Expected results: The implementation of this project aims to achieve results that directly align with the objectives of the Previne Brasil program, which include promoting health, increasing coverage and access to health services, as well as ensuring quality of care, increasing adherence to treatment, and improving health indicators, with a reduction in blood glucose and blood pressure levels. Final considerations: The success of this project will be measured not only by adherence to treatment, but by its ability to transform patients' relationship with their health conditions, promoting individual and collective well-being, benefiting the population living with hypertension and diabetes.